SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-052430
Filing Date
2022-02-24
Accepted
2022-02-24 17:24:01
Documents
4
Effectiveness Date
2022-02-24

Document Format Files

Seq Description Document Type Size
1 S-8 d258268ds8.htm S-8 33890
2 EX-5.1 d258268dex51.htm EX-5.1 5005
3 EX-23.2 d258268dex232.htm EX-23.2 1551
4 EX-FILING FEES d258268dexfilingfees.htm EX-FILING FEES 16503
  Complete submission text file 0001193125-22-052430.txt   57968
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-262997 | Film No.: 22672782
SIC: 2835 In Vitro & In Vivo Diagnostic Substances